Contraceptive Devices Market Analysis

  • Report ID: 3835
  • Published Date: Sep 24, 2025
  • Report Format: PDF, PPT

Contraceptive Devices Market Segmentation:

Technology Segment Analysis

The hormonal contraceptives segment is poised to dominate the contraceptive devices market with a 65.3% revenue share by the end of 2035. The leadership is largely attributed to the increased use of patches and implantable solutions. Moreover, the continued industrial expansion in these categories solidifies the dominance of this technology in this sector for the upcoming years. This can be testified by the explosive global trade value of the subdermal contraceptive implants industry. Furthermore, the heightened awareness efforts from governing bodies and commercial suppliers are enabling continuous growth in this segment.

Product Type Segment Analysis

Condoms are estimated to hold the largest share in the market over the assessed timeline. The capability to offer dual protection against both pregnancy and sexually transmitted infections (STIs), coupled with high accessibility, low cost, and minimal side effects, makes these products the gold standard for this sector. The segment’s predominant captivity over revenue generation can also be evidenced by the amplifying value of global trade in sheath contraceptives, which accounted for USD 822 million in 2023 alone, as per the OEC records. On the other hand, global health initiatives promoting safe intercourse practices are remarkably boosting their adoption.

Distribution Channel Segment Analysis

Retail pharmacies are predicted to be the dominant distribution channel in the contraceptive devices market throughout the discussed period. Their widespread accessibility and convenience make them the preferred choice for consumers seeking products available in this field. Besides, they offer a broad range of over-the-counter (OTC) options, most of which do not require a prescription, enhancing user privacy and ease of purchase. Additionally, pharmacists play an important role in counseling and guiding consumers on proper use based on their retail experience and locality awareness, which boosts an individual’s confidence and adherence to purchasing new launches.

Our in-depth analysis of the global market includes the following segments:

Segment

Subsegment

Product Type

  • Condoms
    • Male
    • Female
  • Intrauterine Devices
    • Hormonal
    • Copper
  • Vaginal Rings
  • Implants
  • Diaphragms
  • Cervical Caps
  • Sponges
  • Others

Technology

  • Hormonal Contraceptives
  • Barrier Contraceptives

Material

  • Latex
  • Non-Latex
    • Polyisoprene
    • Polyurethane
    • Nitrile
  • Silicone
  • Plastic
  • Copper

Gender

  • Male
  • Female

Age Group

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms
  • Clinics
  • Public Channel
  • Others

End user

  • Households/Individuals
  • Hospitals
  • Clinics
  • Community Healthcare Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the contraceptive devices market was over USD 11.4 billion.

The market size for the contraceptive devices market is projected to reach USD 17.6 billion by the end of 2035, expanding at a CAGR of 5% during the forecast period, i.e., between 2026-2035.

The major players in the market are Bayer AG, Merck & Co., Inc. (MSD), Pfizer Inc., AbbVie Inc., Reckitt Benckiser Group plc, CooperCompanies, and others.

In terms of technology, the hormonal contraceptives segment is anticipated to garner the largest market share of 65.3% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 50.1% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos